8-KLeadership ChangesExhibits & Filings

APPLIED MATERIALS INC /DE 8-K Report, Executive Changes (Aug 10, 2015)

Filed August 10, 2015For Securities:AMAT

Summary

Applied Materials, Inc. (AMAT) filed an 8-K on August 10, 2015, to report on the departure of Dr. Randhir Thakur. The filing primarily details the terms of a separation agreement entered into on August 7, 2015. Dr. Thakur, whose departure is expected around October 30, 2015, will receive significant financial compensation and accelerated vesting of certain equity awards as part of his exit. This agreement outlines provisions for continued payments and benefits, contingent upon Dr. Thakur adhering to non-compete, confidentiality, and other obligations. For investors, this filing signals a change in personnel within the company, specifically concerning a key officer. While the specific role of Dr. Thakur is not detailed in this 8-K, the substantial separation package suggests a senior position and aims to ensure a smooth transition and compliance with post-employment restrictions. Investors should note the financial impact of this separation, though the precise details are embedded within the separation agreement itself.

Key Highlights

  • 1Dr. Randhir Thakur is departing Applied Materials, Inc., with his exit expected around October 30, 2015.
  • 2A separation agreement was finalized on August 7, 2015, outlining the terms of Dr. Thakur's departure.
  • 3Dr. Thakur will receive $1,000,000 in cash payments, disbursed in two installments on March 15, 2016, and the one-year anniversary of his departure.
  • 4Accelerated vesting of 168,750 shares and $1,293,750 in cash-settled performance units is part of the agreement.
  • 5Continued payments are conditional on Dr. Thakur not engaging in disqualifying activities and adhering to non-solicitation, confidentiality, and non-disparagement clauses.
  • 6The agreement also includes provisions for benefits if Dr. Thakur is terminated without cause before his planned departure date.
  • 7The separation agreement itself is filed as an exhibit (Exhibit 10.1) to this 8-K for full details.

Frequently Asked Questions

The 8-K filing does not specify Dr. Randhir Thakur's exact role or title. However, the nature of the separation agreement, including significant financial compensation and accelerated vesting of equity awards, suggests he held a senior-level position within the company.

Dr. Thakur is entitled to receive $1,000,000 in cash payments and accelerated vesting of equity valued at $1,293,750 (cash-settled performance units) plus 168,750 shares. The total direct financial value disclosed in the 8-K amounts to approximately $2,293,750, excluding any potential future value of the accelerated shares.

Yes, the cash payments and accelerated vesting are subject to certain conditions. Specifically, Dr. Thakur's right to receive the second and third cash payments is contingent upon him not engaging in disqualifying activities and adhering to his obligations regarding non-solicitation, confidentiality, and non-disparagement as outlined in the agreement.

The agreement includes provisions that would grant Dr. Thakur benefits if he is terminated by Applied Materials without cause prior to his expected departure date of October 30, 2015, subject to certain conditions specified within the agreement.